提供假药罪的违法构造研究

Research on the Illegal Structure of the Crime of Providing Counterfeit Drugs

《刑法修正案(十一)》在原先“生产、销售假药罪”的基础上新增了“提供假药罪”的犯罪类型。对提供假药罪的违法构造进行厘清,行为主体方面,针对怎样划定“药品使用单位”和“药品使用单位人员”的分水岭,可以借助既有的法律规定来判别;行为对象方面,对假药的认定既要考虑医学方面的实际治疗效果,又要考虑药品本身是否具有其“应当具有”的有效药物成分,以及相关成分及含量是否符合我国药典的硬性规定。假药与劣药之界分,应当重新加以考量区分假药与劣药的标准——将假药认定为不具有应有的治疗作用并且转化为有损人体健康的产品。

The Amendment XI to the Criminal Law adds the crime type of“providing counterfeit drugs”based on the original“producing and selling fake drugs”.Due to different subjects involved,it thus possesses the characteristics and conditions of an independent crime.To clarify the illegal structure of the crime of providing counterfeit medicines,the author is inclined to use the existing legal provisions to distinguish the watershed between“drug user unit”and“drug user unit personnel”.In terms of behavior objects,the identification of fake drugs should consider not only the actual treatment effect in medicine,but also whether the drug itself has its“should have”effective drug ingredients,but also whether the drug itself has its“should have”effective drug ingredients,and whether the relevant ingredients and content meet the mandatory provisions of our pharmacopoeia.The distinction between fake and substandard drugs should be reconsidered,and the criteria for distinguishing fake drugs from substandard drugs should be considered as not having the intended therapeutic effect and converted into products that harm human health.